# Virulence of Marek’s disease virus in Japan is linked to polymorphisms in the meq oncogene

**Authors:** Yoshinosuke Motai, Aoi Kurokawa, Jumpei Sato, Shunsuke Yamagami, Shwe Yee Win, Fumiya Horio, Hikaru Saeki, Naoya Maekawa, Tomohiro Okagawa, Benedikt B. Kaufer, Nikolaus Osterrieder, Mark S. Parcells, Satoru Konnai, Kazuhiko Ohashi, Shiro Murata

PMC · DOI: 10.1099/jgv.0.002232 · The Journal of General Virology · 2026-02-19

## TL;DR

This study shows that variations in the Meq protein of Marek’s disease virus in Japan affect how severe the disease is and the symptoms it causes in chickens.

## Contribution

The study identifies how Meq polymorphisms from Japanese isolates alter virulence and clinical outcomes in Marek’s disease.

## Key findings

- Japanese Meq variants showed reduced transrepression and transactivation of viral gene promoters.
- vNr-c1-Meq caused lower mortality and tumourigenicity compared to the highly virulent RB-1B strain.
- Infection with vNr-c1-Meq led to distinct clinical signs and altered immune cell responses in chickens.

## Abstract

Marek’s disease virus (MDV) causes lymphomas and neurological disorders in chickens. Although vaccination largely controls outbreaks, highly virulent strains continue to emerge. The major MDV-encoded oncoprotein is Meq, functions as a transcription factor. Amino acid polymorphisms in Meq have been reported to influence virulence. Despite routine vaccination, MD still occurs sporadically in Japan. Japanese isolates harbour characteristic Meq polymorphisms, but their impact on MDV virulence remains unclear. We investigated the transcriptional regulation by Meq from Japanese isolates and evaluated the pathogenicity of recombinant MDV (rMDV) encoding Meq from the Japanese isolate Nr-c1. Nr-c1-Meq exhibited reduced transrepression and transactivation on viral gene promoters. An rMDV encoding Nr-c1-Meq (vNr-c1-Meq) induced lower mortality and tumourigenicity than an rMDV encoding Meq from the parental very virulent RB-1B strain (vRB-1B). vNr-c1-Meq did not cause visceral tumours or neurological disorders but resulted in distinct clinical signs, including open-mouth breathing. In lymphoid tissues from vNr-c1-Meq-infected chickens, a lower proportion of CD4+ T cells, the targets of MDV transformation, and lower viral loads were observed than those in vRB-1B-infected chickens. Histopathological examination revealed increased lymphocyte infiltration in bronchus-associated lymphoid tissues (BALT) in the vNr-c1-Meq group. Additionally, flow cytometric analysis showed elevated γδ T-cell proportions, which positively correlated with IFN-γ expression in vNr-c1-Meq-infected chickens and were linked to BALT hyperplasia. In comparison to the vRB-1B, vNr-c1-Meq infection resulted in attenuated disease progression and altered clinical signs. These findings suggest that Meq polymorphisms not only influence MD virulence but also clinical presentation.

## Linked entities

- **Proteins:** IFNG (interferon gamma)
- **Diseases:** Marek’s disease (MONDO:0016101)
- **Species:** Gallus gallus (taxon 9031), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** CD3D (CD3 delta subunit of T-cell receptor complex) [NCBI Gene 396518] {aka CD3}, CD4 (CD4 molecule) [NCBI Gene 395362], IL6 (interleukin 6) [NCBI Gene 395337] {aka CHIL-6, IL-6, interleukin-6}, APC (APC, WNT signaling pathway regulator) [NCBI Gene 415607] {aka APC1, CTC-554D6.1}, PRL (prolactin) [NCBI Gene 396453], NOS2 (nitric oxide synthase 2) [NCBI Gene 395807] {aka INOS, NOS2A}, CD8A (CD8A molecule) [NCBI Gene 403158] {aka CD8, CD8-alpha}, HBEGF (heparin binding EGF like growth factor) [NCBI Gene 395654] {aka HB-EGF, HEGFL}, IL1B (interleukin 1, beta) [NCBI Gene 395196] {aka IL-1BETA, IL1beta}, UQCC6 (ubiquinol-cytochrome c reductase complex assembly factor 6) [NCBI Gene 728568] {aka BR, BRAWNIN, C12orf73}, ACTB (actin, beta) [NCBI Gene 396526] {aka Bact, actin}, TLR3 (toll like receptor 3) [NCBI Gene 422720] {aka cTLR3, chTLR3}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 396282] {aka BCL-2, PCKBCL2}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 420027], CTSK (cathepsin K) [NCBI Gene 395818], LITAF (lipopolysaccharide induced TNF factor) [NCBI Gene 374125] {aka TNF-alpha}, CD8B (CD8B molecule) [NCBI Gene 396175] {aka CD8-beta, CD8B1, CD8BP}, TK1 (thymidine kinase 1) [NCBI Gene 395719] {aka TK}, INFG (interferon gamma) [NCBI Gene 396054] {aka IFNG}, JAC1 (Jun-activated cell transformation) [NCBI Gene 425968] {aka CRPs, EDMPN1, JAC, KRTAP10-11, KRTAP10-4, KRTAP10-9}
- **Diseases:** leg paralysis (MESH:D010264), MD (MESH:D008380), MD (MESH:C535955), neurologic dysfunction (MESH:D009461), pulmonary stenosis (MESH:D011666), open-mouth (MESH:D009059), splenomegaly (MESH:D013163), respiratory (MESH:D012131), torticollis (MESH:D014103), lung inflammation (MESH:D011014), paralysis (MESH:D010243), opportunistic infections (MESH:D009894), Tumour (MESH:D009369), open-mouth breathing (MESH:D009058), thymus atrophy (MESH:D001284), CEFs (MESH:D002644), respiratory infections (MESH:D012141), inflammation (MESH:D007249), hyperplasia (MESH:D006965), depression (MESH:D003866), thymic atrophy (MESH:D013953), lymphoma (MESH:D008223), reduced appetite (MESH:D001068), infectious bronchitis (MESH:D001991), infected (MESH:D007239), BALT (MESH:D018442), respiratory or gastrointestinal abnormalities (MESH:D012818)
- **Chemicals:** SDS (MESH:D012967), glutamate (MESH:D018698), tyrosine (MESH:D014443), isoflurane (MESH:D007530), Cy5.5 (MESH:C098793), streptomycin (MESH:D013307), alanine (MESH:D000409), agar (MESH:D000362), proline (MESH:D011392), methanol (MESH:D000432), paraffin (MESH:D010232), eosin (MESH:D004801), lysine (MESH:D008239), Tween 20 (MESH:D011136), PBS (MESH:D007854), Pen (MESH:C058388), CO2 (MESH:D002245), l-glutamine (MESH:D005973), agarose (MESH:D012685), aluminium hydroxide (MESH:D000536), aspartate (MESH:D001224), Lipofectamine 2000 (MESH:C086724), 2-mercaptoethanol (MESH:D008623), Percoll (MESH:C016039), H2O2 (MESH:D006861), NaHCO3 (MESH:D017693), Dulbecco's Modified Eagle's Medium (-), penicillin (MESH:D010406), Haematoxylin (MESH:D006416), G418 (MESH:C010680)
- **Species:** Mycoplasmoides gallisepticum (species) [taxon 2096], Mus musculus (house mouse, species) [taxon 10090], Bordetella avium (species) [taxon 521], Escherichia coli (E. coli, species) [taxon 562], Gallus gallus (bantam, species) [taxon 9031], Gallid alphaherpesvirus 1 (no rank) [taxon 10386], Newcastle disease virus [taxon 11176], Mycoplasmopsis synoviae (species) [taxon 2109], Pasteurella multocida (species) [taxon 747], Infectious bronchitis virus (no rank) [taxon 11120], unidentified influenza virus (species) [taxon 11309], Gallid alphaherpesvirus 2 (Marek disease virus type 1, no rank) [taxon 10390]
- **Mutations:** A217P, P217A, aspartate at positions 71, glutamate-tyrosine, C for 20-24, alanine at positions 176, P176S, lysine-aspartate, phenylalanine at positions 254, alanine residue at position 115, alanine/glutamate, lysine/serine, tyrosine at positions 77, S176P, Pro/Gln, C at 0
- **Cell lines:** RB- — Homo sapiens (Human), Bladder carcinoma, Cancer cell line (CVCL_9828), pRB-1B — Homo sapiens (Human), Childhood B acute lymphoblastic leukemia, Cancer cell line (CVCL_QW66), RB-1B — Homo sapiens (Human), Retinoblastoma, Induced pluripotent stem cell (CVCL_VE63), DF-1 — Gallus gallus (Chicken), Spontaneously immortalized cell line (CVCL_XF08), P3U1 — Mus musculus (Mouse), Mouse multiple myeloma, Cancer cell line (CVCL_3412)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12919941/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12919941/full.md

## References

72 references — full list in the complete paper: https://tomesphere.com/paper/PMC12919941/full.md

---
Source: https://tomesphere.com/paper/PMC12919941